69 related articles for article (PubMed ID: 11037109)
1. Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol.
Atalla A; Breyer-Pfaff U; Maser E
Xenobiotica; 2000 Aug; 30(8):755-69. PubMed ID: 11037109
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Analysis of mRNA and Protein Expression Levels of Aldo-Keto Reductase and Short-Chain Dehydrogenase/Reductase Isoforms in the Human Intestine.
Hirosawa K; Fujioka H; Morinaga G; Fukami T; Ishiguro N; Kishimoto W; Nakase H; Mizuguchi H; Nakajima M
Drug Metab Dispos; 2023 Dec; 51(12):1569-1577. PubMed ID: 37722844
[TBL] [Abstract][Full Text] [Related]
3. The aldo-keto reductases (AKRs): Overview.
Penning TM
Chem Biol Interact; 2015 Jun; 234():236-46. PubMed ID: 25304492
[TBL] [Abstract][Full Text] [Related]
4. Identification and functional characterization of a novel aldo-keto reductase from Aloe vera.
Jangra A; Chaturvedi S; Sihag S; Sharma G; Tiwari S; Chhokar V
Planta; 2023 Oct; 258(6):107. PubMed ID: 37897513
[TBL] [Abstract][Full Text] [Related]
5. Expression of a constitutively active nitrate reductase variant in tobacco reduces tobacco-specific nitrosamine accumulation in cured leaves and cigarette smoke.
Lu J; Zhang L; Lewis RS; Bovet L; Goepfert S; Jack AM; Crutchfield JD; Ji H; Dewey RE
Plant Biotechnol J; 2016 Jul; 14(7):1500-10. PubMed ID: 26800860
[TBL] [Abstract][Full Text] [Related]
6. An NADH/NAD
Zhang D; Wang Y; Tang Q; Zhang Q; Ji X; Qiu X; Chen D; Liu W
Appl Environ Microbiol; 2024 Apr; 90(4):e0015024. PubMed ID: 38551341
[TBL] [Abstract][Full Text] [Related]
7. Decoding selectivity: computational insights into AKR1B1 and AKR1B10 inhibition.
Liu M; Qin X; Li J; Jiang Y; Jiang J; Guo J; Xu H; Wang Y; Bi H; Wang Z
Phys Chem Chem Phys; 2024 Mar; 26(12):9295-9308. PubMed ID: 38469695
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing in the aldo-keto reductase superfamily: implications for protein nomenclature.
Barski OA; Mindnich R; Penning TM
Chem Biol Interact; 2013 Feb; 202(1-3):153-8. PubMed ID: 23298867
[TBL] [Abstract][Full Text] [Related]
9. Stereospecific Metabolism of
Barnette DA; Johnson BP; Pouncey DL; Nshimiyimana R; Desrochers LP; Goodwin TE; Miller GP
Drug Metab Dispos; 2017 Sep; 45(9):1000-1007. PubMed ID: 28646078
[TBL] [Abstract][Full Text] [Related]
10. Aldo-Keto Reductase AKR1C1-AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy.
Zeng CM; Chang LL; Ying MD; Cao J; He QJ; Zhu H; Yang B
Front Pharmacol; 2017; 8():119. PubMed ID: 28352233
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 3-[(N-carboalkoxy)ethylamino]-indazole-dione derivatives and their biological activities on human liver carbonyl reductase.
Berhe S; Slupe A; Luster C; Charlier HA; Warner DL; Zalkow LH; Burgess EM; Enwerem NM; Bakare O
Bioorg Med Chem; 2010 Jan; 18(1):134-41. PubMed ID: 19959367
[TBL] [Abstract][Full Text] [Related]
12. Aldo-keto reductase 1C2 (AKR1C2) as the second gene associated to non-syndromic primary lipedema: investigating activating mutation or overexpression as causative factors.
Kaftalli J; Donato K; Bonetti G; Dhuli K; Macchia A; Maltese PE; Louise Herbst K; Michelini S; Chiurazzi P; Hill M; Michelini S; Michelini S; Marceddu G; Bernini A; Bertelli M
Eur Rev Med Pharmacol Sci; 2023 Dec; 27(6 Suppl):127-136. PubMed ID: 38112953
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of the reductive carbonyl idarubicin metabolism to evaluate inhibitors of the formation of cardiotoxic idarubicinol via carbonyl and aldo-keto reductases.
Bajraktari-Sylejmani G; Oster JS; Burhenne J; Haefeli WE; Sauter M; Weiss J
Arch Toxicol; 2024 Mar; 98(3):807-820. PubMed ID: 38175295
[TBL] [Abstract][Full Text] [Related]
14. Electron withdrawing group-dependent substrate inhibition of an α-ketoamide reductase from Saccharomyces cerevisiae.
Akbary Z; Yu H; Lorenzo I; Paez K; Lee ND; DeBeVoise K; Moses J; Sanders N; Connors N; Cassano A
Biochem Biophys Res Commun; 2023 Oct; 676():97-102. PubMed ID: 37499370
[TBL] [Abstract][Full Text] [Related]
15. The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative.
Persson B; Kallberg Y; Bray JE; Bruford E; Dellaporta SL; Favia AD; Duarte RG; Jörnvall H; Kavanagh KL; Kedishvili N; Kisiela M; Maser E; Mindnich R; Orchard S; Penning TM; Thornton JM; Adamski J; Oppermann U
Chem Biol Interact; 2009 Mar; 178(1-3):94-8. PubMed ID: 19027726
[TBL] [Abstract][Full Text] [Related]
16. Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7, 8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the activated o-quinone metabolite benzo[a]pyrene-7,8-dione.
Burczynski ME; Harvey RG; Penning TM
Biochemistry; 1998 May; 37(19):6781-90. PubMed ID: 9578563
[TBL] [Abstract][Full Text] [Related]
17. AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway.
Chang WM; Chang YC; Yang YC; Lin SK; Chang PM; Hsiao M
J Exp Clin Cancer Res; 2019 Jun; 38(1):245. PubMed ID: 31182137
[TBL] [Abstract][Full Text] [Related]
18. Effects of cellular differentiation in human primary bronchial epithelial cells: Metabolism of 4-(methylnitrosamine)-1-(3-pyridyl)-1-butanone.
Qin Q; Wu Q; Wang Y; Xiong R; Guo L; Fu X; Rosenfeldt H; Bryant M; Cao X
Toxicol In Vitro; 2019 Mar; 55():185-194. PubMed ID: 30552994
[TBL] [Abstract][Full Text] [Related]
19. Carbonyl reduction of NNK by recombinant human lung enzymes: identification of HSD17β12 as the reductase important in (R)-NNAL formation in human lung.
Ashmore JH; Luo S; Watson CJW; Lazarus P
Carcinogenesis; 2018 Jul; 39(8):1079-1088. PubMed ID: 29788210
[TBL] [Abstract][Full Text] [Related]
20. Association between CBR1 polymorphisms and NSCLC in the Chinese population.
Guo Y; Shen Y; Xia Y; Gu J
Oncol Lett; 2017 Nov; 14(5):6291-6297. PubMed ID: 29113280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
